Fenetylline: Difference between revisions
Gerald Chi (talk | contribs) mNo edit summary |
Gerald Chi (talk | contribs) mNo edit summary |
||
Line 3: | Line 3: | ||
| verifiedrevid = 461099552 | | verifiedrevid = 461099552 | ||
| IUPAC_name = (''RS'')-1,3-dimethyl- 7-[2-(1-phenylpropan-2-ylamino)ethyl]purine- 2,6-dione | | IUPAC_name = (''RS'')-1,3-dimethyl- 7-[2-(1-phenylpropan-2-ylamino)ethyl]purine- 2,6-dione | ||
| image = Fenethylline.png | | image =Fenethylline.png | ||
| width = 200px | | width = 200px | ||
| imagename = 1 : 1 mixture (racemate) | | imagename = 1 : 1 mixture (racemate) |
Latest revision as of 23:09, 15 April 2015
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C18H23N5O2 |
Molar mass | 341.408 g/mol |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
WikiDoc Resources for Fenetylline |
Articles |
---|
Most recent articles on Fenetylline Most cited articles on Fenetylline |
Media |
Powerpoint slides on Fenetylline |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Fenetylline at Clinical Trials.gov Clinical Trials on Fenetylline at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Fenetylline
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Fenetylline Discussion groups on Fenetylline Patient Handouts on Fenetylline Directions to Hospitals Treating Fenetylline Risk calculators and risk factors for Fenetylline
|
Healthcare Provider Resources |
Causes & Risk Factors for Fenetylline |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Fenethylline (BAN, USAN), also spelled phenethylline and fenetylline (INN), and also known as amphetaminoethyltheophylline and amfetyline, is a chemical linkage of amphetamine and theophylline which behaves as a prodrug to both of the aforementioned drugs.[1][2] It is marketed for use as a psychostimulant under the brand names Captagon, Biocapton, and Fitton.[1][2]
History
Fenethylline was invented by Degussa AG in 1961[3] and used for around 25 years as a milder alternative to amphetamines. Despite no accepted FDA indication for fenethylline, it was used in applications such as treating "hyperkinetic children" (what would now be referred to as Attention Deficit Hyperactivity Disorder), and also less commonly for treating narcolepsy or as an antidepressant. One of the main advantages of fenethylline was that it does not tend to increase blood pressure to the same extent as amphetamines and so could be used in patients with cardiovascular conditions.
Fenethylline was considered to have fewer side effects and less potential for abuse than amphetamine. Nevertheless, fenethylline was listed in 1981 as a schedule I controlled substance in the US, and it became illegal in most countries in 1986 after being listed by the World Health Organization for international scheduling under the Convention on Psychotropic Substances, even though the actual incidence of fenethylline abuse was quite low.
Pharmacology
Fenethylline is metabolized by the body to form two drugs amphetamine (24.5% of oral dose) and theophylline (13.7% of oral dose), both of which are active stimulants themselves.[4] The physiological effects of fenethylline therefore result from a combination of all three drugs.[5]
Abuse
Abuse of fenethylline of the brand name Captagon is most common in Arab countries and counterfeit versions of the drug continue to be available despite its illegality.[6] [7]
Many of these counterfeit "Captagon" tablets actually contain other amphetamine derivatives that are easier to produce, but are pressed and stamped to look like Captagon pills. Some counterfeit Captagon pills analyzed do contain fenethylline however, indicating that illicit production of this drug continues to take place.[citation needed]
Fenethylline is a popular drug, allegedly used by militant groups in Syria and Lebanon. It is manufactured locally in a cheap and simple process. According to some leaks, militant groups would also export the drug in exchange for weapons and cash.[8][9]
See also
References
- ↑ 1.0 1.1 Dictionary of Organic Compounds. CRC Press. pp. 3140–. ISBN 978-0-412-54090-5.
- ↑ 2.0 2.1 Index Nominum 2000: International Drug Directory. Taylor & Francis. January 2000. pp. 431–. ISBN 978-3-88763-075-1.
- ↑ Fenetylline: therapeutic use, misuse and/or abuse. Kristen G, Schaefer A, von Schlichtegroll A. Drug Alcohol Dependence. 1986 Jun;17(2-3):259-71.
- ↑ Ellison T, Levy L, Bolger JW, Okun R. The metabolic fate of 3H-fenethylline in man. European Journal of Pharmacology 13:123, 1970.
- ↑ Chemical characterization of counterfeit captagon tablets seized in Jordan. Alabdalla MA. Forensic Science International. 2005 Sep 10;152(2-3):185-8.
- ↑ "2011 Global Assessment of Amphetamine-Type Stimulants" (PDF). United Nations Office on Drugs and Crime.
- ↑ "Le Captagon®, arme principale des jihadistes". Reseau Voltaire.
- ↑ Colin Freeman (2014-01-12). "Syria's civil war being fought with fighters high on drugs". The Telegraph. Retrieved 2014-01-13.
- ↑ Stephen Kalin (2014-01-12). "Insight: War turns Syria into major amphetamines producer, consumer". Reuters. Retrieved 2014-04-21.
- Pages with script errors
- Template:drugs.com link with non-standard subpage
- Articles with changed CASNo identifier
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Infobox drug articles with non-default infobox title
- Articles without EBI source
- Drugboxes which contain changes to verified fields
- All articles with unsourced statements
- Articles with unsourced statements from January 2014
- Articles with invalid date parameter in template
- Xanthines
- Prodrugs
- Stimulants